← Back to Clinical Trials
Recruiting NCT07511387

NCT07511387 Efficacy of a Novel Myopia Defocus Spectacle Lens in School-Aged Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07511387
Status Recruiting
Phase
Sponsor The Hong Kong Polytechnic University
Condition Myopia
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-04-10
Primary Completion 2026-12

Trial Parameters

Condition Myopia
Sponsor The Hong Kong Polytechnic University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 6 Years
Max Age 15 Years
Start Date 2026-04-10
Completion 2026-12
Interventions
BCMC lens

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to evaluate the short-term efficacy and safety of a novel, proprietary spectacle lens. Forty myopic participants, aged 6 to 15 years, will be prescribed with the study spectacles for a period of six months. All subjects will be required to attend five scheduled visits. Change in subfoveal choroidal thickness (SfChT), axial length and refraction will be determined.

Eligibility Criteria

Inclusion Criteria: * Age 6 to 15 years (Chinese), inclusive * Cycloplegic SER between -0.75 D and -6.00 D in both eyes * Astigmatism ≤ 2.00 D in both eyes * Anisometropia ≤ 1.50 D * BCVA of 0.04 logMAR or better in each eye Exclusion Criteria: * Previous or current use of any myopia control intervention within 6 months * Presence of any ocular pathology, amblyopia, colour vision deficiency or strabismus that could affect refractive development or visual function * History of ocular surgery or significant ocular trauma * Known systemic diseases or use of medications that could affect vision or ocular growth

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology